trending Market Intelligence /marketintelligence/en/news-insights/trending/1dIHA2TkS-jEpSu3eN_Pxg2 content esgSubNav
In This List

US appeals court defeats lawsuits against Pfizer anti-depressant

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


US appeals court defeats lawsuits against Pfizer anti-depressant

Attempts to revive over 300 lawsuits alleging Pfizer Inc. downplayed the risks of Zoloft in pregnant women was defeated by the U.S. 3rd Circuit Court of Appeals in Philadelphia, Reuters reported.

The plaintiffs alleged the anti-depressant caused cardiac birth defects when taken by women during early pregnancy. However, the court noted that the plaintiffs were unable to show a scientific link between Zoloft and the cardiac birth defects.

The lawsuits were previously defeated in a lower court in April 2016, and it is yet unclear if the plaintiffs will request another appeal or a rehearing.